Karl Storz has received FDA clearance for its Rubina Lens exoscope, expanding the company’s near-infrared (NIR) imaging technology into open surgical procedures in the US.
The camera-based system provides surgeons with a real-time, magnified 4K view of the surgical field and can switch to NIR imaging using indocyanine green (ICG) to highlight information not visible to the naked eye.
Related: Xenix Medical announces FDA clearance and full commercial launch of the Lux System
The Rubina Lens is cleared for applications including tissue perfusion assessment, lymphatic mapping, and breast surgery, supporting more informed decisions during operations. It can be used handheld or mounted on a surgical arm and integrates with existing Karl Storz imaging platforms.
Fernando Morales, Vice President of Surgical & OR Integration at KARL STORZ United States, said:
“The Rubina Lens extends real-time fluorescence visualization into open surgery, integrating seamlessly with existing OR platforms.”
The approval strengthens Karl Storz’s imaging ecosystem by bringing advanced fluorescence visualization to a wider range of surgical settings.
